Holmes’s lawyer pointed out instances when she encouraged transparency in Theranos’s marketing language. Holmes had been “very involved and detail oriented” in reviewing and approving all marketing and investor materials. An example was language claiming that Theranos’s machines could run “any test available in central labs” using blood only “1/1,000 the size of a typical blood draw.”īut similar language made it to investor presentations, documents showed. In emails shown to jurors, the start-up’s lawyer, Kate Beardsley, marked draft website copy as potentially misleading. Other questions concerned Theranos’s marketing. Edlin said a Theranos executive had instructed him to remove some results before sending Mr. Murdoch’s test results came back with various issues. Any blood results?”Īccording to an email sent to Mr. Murdoch had his blood drawn in a demonstration in January 2015.
In some cases, he said, Theranos also removed abnormal results before sending out reports to investors who had tested the company’s technology, such as Rupert Murdoch, the media mogul.
Edlin testified that Theranos sometimes hid failures or didn’t even try to analyze a blood sample during technology demonstrations.
Holmes’s brother who became a senior product manager at Theranos. This week’s star witness was Daniel Edlin, a college friend of Ms.
0 kommentar(er)
